We’re Evolving—Immortality.global 2.0 is Incubating
The platform is in maintenance while we finalize a release that blends AI and longevity science like never before.

July 10 in Longevity and AI

Gathered globally: 8, selected: 7.

The News Aggregator is an artificial intelligence system that gathers and filters global news on longevity and artificial intelligence, and provides tailored multilingual content of varying sophistication to help users understand what's happening in the world of longevity and AI.


Stanford’s Wyss-Coray lab harnesses large-scale plasma proteomics and LASSO modeling to derive organ-specific ‘age gaps’ for 11 human organs. They identify organ-enriched plasma proteins and train age predictors on UK Biobank data (~45,000 participants). The resulting age gaps correlate with lifestyle factors, forecast incident diseases—from heart failure to Alzheimer’s—and reveal that youthful brain and immune profiles confer substantial longevity benefits.

Key points

  • Applied Olink plasma proteomics (~3,000 proteins) with GTEx‐defined organ enrichment to train LASSO regression models for 11 organ‐specific age predictions.
  • Calculated z-scored ‘age gaps’ that forecasted 15 incident diseases, including heart failure and Alzheimer’s, with hazard ratios up to 8.3 for multi‐organ aging.
  • Demonstrated that extreme brain and immune age gaps rival APOE genotype effects—aged brains triple Alzheimer’s risk and youthful profiles halve mortality risk.

Why it matters: This plasma proteomics approach enables noninvasive tracking of organ health, offering personalized disease risk profiling and new targets for longevity interventions.

Q&A

  • What is an “age gap”?
  • How are organ-enriched proteins chosen?
  • Why use plasma proteomics for aging?
  • How do brain age gaps compare to APOE genotypes?
Copy link
Facebook X LinkedIn WhatsApp
Share post via...
Plasma proteomics links brain and immune system aging with healthspan and longevity

An international team led by Xi’an Jiaotong University used a swimming regimen in juvenile C57BL/6J mice to reveal that three months of early-life exercise confers lasting improvements in lean mass, cardiovascular function, muscle strength, and reduced inflammation, while failing to alter median lifespan.

Key points

  • Three months of early-life swimming in C57BL/6J mice improves healthspan metrics—including lean mass, muscle strength, and cardiovascular function—without altering median lifespan.
  • Multi-tissue RNA-seq identifies upregulated fatty acid metabolism and PPAR signaling pathways in aged skeletal muscle as key exercise-induced anti-aging signatures.
  • Early-life exercise reduces inflammaging and frailty, evidenced by lower granulocyte-to-lymphocyte ratios, decreased tissue macrophage infiltration, and improved frailty index scores.

Why it matters: These findings reveal how early-life exercise programs healthier aging and identifies fatty acid metabolism as a target for anti-aging strategies.

Q&A

  • What is the difference between healthspan and lifespan?
  • How can exercise improve health without extending lifespan?
  • Why focus on fatty acid metabolism in skeletal muscle?
  • What is the frailty index used in mouse studies?
  • What are Rev-aging DEGs in this research?
Copy link
Facebook X LinkedIn WhatsApp
Share post via...
Early-Life Exercise Extends Healthspan but Not Lifespan in Mice

Emory University scientists demonstrate that psilocybin—via its active metabolite psilocin—extends human cell lifespan by preserving telomeres and enhancing DNA repair, and increases survival by 30% in aged mice through reduced oxidative stress.

Key points

  • Psilocybin’s active metabolite psilocin extends human skin and lung cell lifespan by over 50%, linked to enhanced DNA repair and telomere preservation.
  • In aged mice, a regimen of 5 mg initial and 15 mg monthly psilocybin yields a 30% increase in survival and improved physical health biomarkers.
  • Mechanistic studies reveal attenuation of oxidative stress, activation of DNA repair pathways, and maintenance of telomeric integrity as core anti‐aging effects.

Why it matters: These findings position psilocybin as a novel geroprotective candidate, offering multi‐targeted anti‐aging mechanisms beyond conventional senolytics and antioxidants.

Q&A

  • What is psilocybin and how does it convert to its active form?
  • How does psilocybin treatment preserve telomere length?
  • Which aging hallmarks are targeted by psilocybin in this study?
  • What are the next steps to translate these findings to humans?
Copy link
Facebook X LinkedIn WhatsApp
Share post via...
Psilocybin Shows Promise as Anti-Aging Therapy

A team at University Hospital Regensburg implements an AI-based convolutional neural network to classify standard facial images, identifying synkinesis in patients with facial palsy. The network processes cropped and resized data through convolutional, activation, pooling, and normalization layers, delivering 98.6% test accuracy. Integrated into a lightweight web interface, this tool supports timely and objective patient triage.

Key points

  • Convolutional neural network with multiple convolutional, ReLU, pooling, and batch normalization layers classifies facial synkinesis.
  • Dataset of 385 images split into 285 training, 29 validation, and 71 test images ensures no patient overlap during evaluation.
  • Model achieves 98.6% accuracy, 100% precision, and 96.9% recall with an average processing time of 24±11 ms per image.

Why it matters: This AI screening tool accelerates facial synkinesis diagnosis, reducing specialist referral delays and enabling earlier, objective intervention in facial palsy care.

Q&A

  • What is facial synkinesis?
  • How does a convolutional neural network (CNN) work?
  • What do precision, recall, and F1-score indicate?
  • Why is data standardization important in the study?
  • How can clinicians use this web application?
Copy link
Facebook X LinkedIn WhatsApp
Share post via...
Diagnosing facial synkinesis using artificial intelligence to advance facial palsy care

BMC Medical Imaging investigators implement a radiomics pipeline extracting high-order texture features from NCCT scans, co-registered with diffusion-weighted MRI, to train a random forest classifier that accurately discriminates acute ischemic stroke lesions within six hours, facilitating rapid, accessible early diagnosis.

Key points

  • Co-registered NCCT and DWI images from 228 acute ischemic stroke patients enable precise infarct labeling for radiomic analysis.
  • Ten RPT-selected radiomic features—including wavelet, LoG, and gradient textures—are normalized and input into a random forest classifier.
  • Model achieves AUROCs of 0.858/0.829/0.789 and accuracies up to 79.4%, enabling subvisual infarct detection within six hours on standard CT.

Why it matters: Subvisual stroke lesion detection on routine CT scans expedites early intervention and democratizes acute ischemic stroke diagnosis in resource-limited settings.

Q&A

  • What is radiomics?
  • How are CT and MRI data aligned?
  • Why use a random forest classifier?
  • What are LoG and wavelet filters in radiomics?
Copy link
Facebook X LinkedIn WhatsApp
Share post via...
A machine learning model reveals invisible microscopic variation in acute ischaemic stroke (≤ 6 h) with non-contrast computed tomography

InsightAce Analytic releases a comprehensive market assessment on global longevity and anti-senescence therapies. The report evaluates therapy segments—including senolytic drugs, gene and cell therapies—across applications from cardiovascular disease to cancer, projecting USD 4.12 billion by 2030 at a 6.8% CAGR.

Key points

  • Market grows from USD 2,736.43 million (2023) to USD 4,121.54 million (2030) at 6.8% CAGR
  • Therapy modalities analyzed: senolytic drugs, gene, cell, mitochondrial, immunotherapy, others
  • Regional breakdown with North America leading; Asia Pacific poised for rapid growth due to R&D expansion

Why it matters: A growing anti-aging therapy market signals readiness for translational interventions that may extend healthy lifespan and mitigate chronic disease burdens globally.

Q&A

  • What is anti-senescence therapy?
  • What drives a 6.8% CAGR in this market?
  • Which therapy segments are most prominent?
  • Why is North America the largest regional market?
Copy link
Facebook X LinkedIn WhatsApp
Share post via...
Longevity and Anti-Senescence Therapy Market Growth and Restrain Factors Analysis Report

Lottery Unlocked, developed by a leading predictive analytics team, uses neural networks and quantum probability vectors to analyze over 5 billion lottery draws, delivering 83% prediction accuracy to transform random number selection into a data-driven strategy for serious players.

Key points

  • Neural network and quantum-probability vector integration analyzes over 5 billion historical lottery draws.
  • Quantum+ Algorithm on a 14.8 teraflop neural processor achieves 83% predictive accuracy and 3.2× ROI.
  • Adaptive machine learning models continuously refine number selection strategies across multiple lottery formats.

Why it matters: This AI-quantum approach represents a paradigm shift, offering data-driven lottery strategies that dramatically outperform traditional random selection methods.

Q&A

  • What is a quantum probability vector?
  • How is predictive accuracy measured?
  • What are adaptive machine learning models?
  • Does higher ROI guarantee profit?
Copy link
Facebook X LinkedIn WhatsApp
Share post via...
Best AI Lottery System of 2025? Lottery Unlocked Review Reveals 83% Predictive Accuracy Backed by Quantum Algorithms